Cart summary

You have no items in your shopping cart.

T56-LIMKi

SKU: orb1303512

Description

T56-LIMKi (T5601640) is a potent and selective small molecule inhibitor targeting LIMK2. This compound is a valuable research tool for investigating LIMK2's role in cytoskeletal dynamics, cell motility, and metastasis in both cellular and animal models of cancer and neurological disorders.

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number924473-59-6
MW389.33
Purity99.57% (May vary between batches)
FormulaC19H14F3N3O3
SMILESCc1cc(on1)C(=O)Nc1cccc(c1)C(=O)Nc1cccc(c1)C(F)(F)F
TargetLIM Kinase
Solubility10% DMSO+90% Corn Oil:2.5 mg/mL (6.42 mM);DMSO:50 mg/mL (128.43 mM)

Bioactivity

Target IC50
LIMK2:35.2 μM.
In Vivo
T56-LIMKi induces inhibition of cofilin phosphorylation and promotes Panc-1 tumor shrinkage in vivo, with mice treated with T56-LIMKi (60 mg/kg) showing a significant decrease in tumor volume compared to controls.
In Vitro
T56-LIMKi effectively suppresses the proliferation of various cancer cell lines, including ST88-14, U87, Panc-1, and A549 lung cancer cells, exhibiting IC50 values of 18.3, 7.4, 35.2, and 90 µM respectively. It significantly lowers phosphorylated cofilin (p-cofilin) levels, impairing the growth of pancreatic, glioma, and schwannoma cancer cells. This compound inhibits cofilin phosphorylation, crucial for actin disruption, thereby preventing tumor cell movement, proliferation, and the formation of colonies in soft agar without contact. At concentrations ranging from 10-50 µM, T56-LIMKi dose-dependently decreases p-cofilin in NF1−/− MEFs, with a 30 µM IC50, while not affecting total cofilin levels. Furthermore, a 50 µM dosage of T56-LIMKi significantly reduces the presence of stress fibers in cells.
Cell Research
T56-LIMKi can induce inhibition of cofilin phosphorylation and Panc-1 tumor shrinkage in vivo. Mice treated with T56-LIMKi (60 mg/kg) shows a significant decrease in tumor volume compared to control.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

inhibit, LIM Kinase, LIM Kinase (LIMK), LIMK2, LIMKinase, LIMKs, Inhibitor, T 5601640, T56 LIMKi, T5601640, T-5601640, T56LIMKi, T-56-LIMKi, T56-LIMKi

Similar Products

  • T56-LIMKi [orb1222992]

    >98% (HPLC)

    924473-59-6

    389.3

    C19H14F3N3O3

    500 mg, 10 mg, 25 mg, 50 mg, 100 mg, 2 mg, 1 g, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

T56-LIMKi (orb1303512)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 80.00
1 ml x 10 mM (in DMSO)
$ 90.00
10 mg
$ 110.00
25 mg
$ 180.00
50 mg
$ 270.00
100 mg
$ 390.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry